SCHEMBL7739017

SCHEMBL7739017

COc1cccc(-c2nc(-c3ccccc3-c3cccc(O)c3)oc2NC(C)=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.62
FLT1 P17948 1/20 0.58
FLT4 P35916 1/20 0.58
KDM4E B2RXH2 1/20 0.49
HSP90AA1 P07900 2/20 0.48
HSP90AB1 P08238 1/20 0.48
ADORA3 P0DMS8 2/20 0.47
ADORA2B P29275 2/20 0.47
ADORA1 P30542 2/20 0.47
ADORA2A P29274 1/20 0.47
FABP4 P15090 1/20 0.45
MAPT P10636 3/20 0.44
TP53 P04637 2/20 0.44
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 2/20 0.43
RAB9A P51151 2/20 0.43
HSD17B10 Q99714 2/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738996 0.89 KDR (0.52) KDRFLT1FLT4KDM4EHSP90AA1
SCHEMBL7744668 0.88 KDR (0.69) KDRFLT1FLT4KDM4EADORA1
SCHEMBL7739010 0.86 KDR (0.47) KDRFLT1FLT4KDM4EHSP90AA1
SCHEMBL7739080 0.86 KDR (0.62) KDRFLT1FLT4HSP90AA1HSP90AB1
SCHEMBL7739015 0.84 KDR (0.68) KDRFLT1FLT4KDM4EHSP90AA1
SCHEMBL7739089 0.84 KDR (0.60) KDRFLT1FLT4KDM4EHSP90AA1
SCHEMBL7739016 0.83 KDR (0.56) KDRFLT1FLT4MAPTALDH1A1
SCHEMBL7744664 0.82 KDR (0.55) KDRFLT1FLT4KDM4EFABP4
SCHEMBL7746642 0.82 KDR (0.55) KDRFLT1FLT4FABP4MAPT
SCHEMBL7744772 0.82 KDR (0.61) KDRFLT1FLT4ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed